EAN 2021: Ocrelizumab-Treated Patients With Multiple Sclerosis Have Typical COVID-19 Disease Trajectory
Risk factors for severe disease were similar to those observed in the general population
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.